AHPA to host hemp event in Colorado in August

By Hank Schultz contact

- Last updated on GMT

© Getty Images / MysteryShot
© Getty Images / MysteryShot
The American Herbal Products Association is planning a hemp/CBD event in August in Colorado for dietary supplement companies interested in the ingredient.

The event, billed as the Hemp-CBD Supplement Congress, will take place on August 15 and 16 in Denver.  The venue, the Crown Plaza hotel, is located at 1450 Glenarm Place downtown.

Colorado is hotbed of CBD innovation

Colorado was an early adopter in the cannabis game, so interest in ingredients derived from the plant has been high in the state. Another hemp/CBD event, the NoCo Hemp Expo​, took place earlier this year at another Crown Plaza hotel in Denver that is closer to the airport, one that also has an exhibit space. That two day event drew 10,000 attendees, which was the maximum the venue could accommodate.

Also, just yesterday the state’s agriculture department announced the CHAMP Initiative​, or the Colorado Hemp Advancement and Management Plan.  The goal of the effort is to help the state maintain its lead in hemp cultivation and extraction.

The workshops and presentations at the AHPA event will address the rapidly evolving legal, regulatory and financial landscapes surrounding hemp products, including cannabidiol (CBD). Speakers from the Food and Drug Administration and the US Department of Agriculture will discuss their agencies’ approach to regulating hemp-CBD and supplements made with these ingredients.

Sessions to include NDI and GRAS requirements

Thursday’s half-day workshops will cover two regulatory issues: compliance with the FDA’s current good manufacturing practice (cGMP) requirements for dietary supplements; and new dietary ingredient and generally recognized as safe for hemp as a food additive or dietary ingredient. EAS Consulting Group will provide cGMP training, while AIBMR Life Sciences will present NDI and GRAS requirements.

Friday, industry experts and government officials will present on a host of issues facing hemp-CBD companies:

  • Getting to Market: Hemp Supply Chain Management
  • Overcoming Regulatory Obstacles: Updates from the FDA, USDA and Individual States 
  • Primer on FDA Regulation of Hemp-CBD Supplements
  • The Hemp-CBD Supplement Market: A Financial Snapshot
  • Hemp-CBD Supplements from the Retailers' Perspective

USDA, FDA officials to present

Notable sessions include a presentation from USDA Agricultural Marketing Service senior marketing specialist William Richmond, who will provide an update on USDA efforts related to the recent decriminalization of hemp. In addition, the FDA will provide an update on the agency's ongoing efforts to design and implement a regulatory framework to ensure informed access to safe, legal products. Richmond leads the USDA, Agricultural Marketing Service, Specialty Crops Program in Washington, DC, and is responsible for establishment and implementation of the US Domestic Hemp Production Program.

Related news

Show more

Related products

show more

Gemini Pharmaceuticals and Transparency

Gemini Pharmaceuticals and Transparency

Gemini Pharmaceuticals | 01-Sep-2019 | Application Note

The industry has shown improvement in its transparency in the past 5 years. Per the regulations, a Brand Owner is 100% responsible for the quality of...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars